BG
MTEM

BlackRock Group’s Molecular Templates, Inc. MTEM Stock Holding History

BlackRock Group’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4
Closed -$3K – 2800
2013
Q3 		$3K Buy
+4
New +$3.29K ﹤0.01% 2886

Other funds holding MTEM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Group's MTEM Position: Q4 2013 in Review

BlackRock Group sold out of Molecular Templates, Inc. (MTEM) in Q4 2013, closing a stake of 4 shares — an estimated $3K sold.

BlackRock Group first reported a position in MTEM in Q3 2013 and held it in 1 quarter. The position peaked at $3K in Q3 2013. 87 funds tracked by Wall St. Rank hold MTEM as of Q4 2013.

  • BlackRock Group reported no remaining Molecular Templates, Inc. position as of Q4 2013 after selling out during the quarter.
  • BlackRock Group sold 4 Molecular Templates, Inc. shares in Q4 2013, an estimated $3K.
  • BlackRock Group first reported a position in Molecular Templates, Inc. in Q3 2013 and held it in 1 quarter.
  • BlackRock Group's Molecular Templates, Inc. position peaked at $3K in Q3 2013.
  • 87 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.